Please login to the form below

Not currently logged in
Email:
Password:

GlycoVaxyn

This page shows the latest GlycoVaxyn news and features for those working in and with pharma, biotech and healthcare.

GSK's pivotal TB vaccine could prevent millions of deaths

GSK's pivotal TB vaccine could prevent millions of deaths

GSK has made vaccines a pillar of its strategy since taking control of Novartis’ vaccine business in 2014, which it then followed up with a $190m deal for vaccine specialist GlycoVaxyn

Latest news

  • GSK buys vaccine specialist GlycoVaxyn for $190m GSK buys vaccine specialist GlycoVaxyn for $190m

    Acquisition will expand GSK’s early vaccines pipeline.  . GlaxoSmithKline (GSK) has taken control of Swiss company GlycoVaxyn in a $190m deal that bolsters its early vaccines pipeline. ... GSK already owned a stake in GlycoVaxyn and had been working

  • Janssen boosts vaccines pipeline with GlycoVaxyn deal

    He said: “This collaboration is a further confirmation of the position GlycoVaxyn is about to occupy in the vaccine development space. ... The whole team is dedicated to establish GlycoVaxyn's technology as a powerful platform able to generate

More from news
Approximately 2 fully matching, plus 1 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
An agency called Owen

We’re a Healthcare Communications Agency specialising in Multi-channel Marketing to make you Digitally Fitter, Stronger & Faster....

Latest intelligence

Data desires
What are you looking to achieve with data and how are you preparing yourself to react to the results?...
The balancing act that’s keeping pharma and biotech market access on its toes
Pricing drugs and gaining reimbursement can be a real challenge for drug developers. Price it too high, and no one buys it. Price it too low, and it’s hard to...
Pills
Tackling antimicrobial resistance on multiple fronts
An urgent change of direction is needed in how we respond to AMR...

Infographics